Mostly water and electrolytes derived from maternal plasma.
Contains antibodies, enzymes, and hormones (such as alpha-fetoprotein) used to screen for developmental issues. Clinical Purpose of Testing "Amnio Content" Mostly water and electrolytes derived from maternal plasma
Testing fetal cells for chromosomal abnormalities like Down syndrome or cystic fibrosis. Mostly water and electrolytes derived from maternal plasma
Checking for the presence of harmful bacteria or viruses in cases of suspected intrauterine infection. The Procedure at a Glance Mostly water and electrolytes derived from maternal plasma
In late pregnancy, it can be tested for surfactant levels to assess if the baby's lungs are developed enough for delivery.
Medical providers analyze this fluid during an procedure (typically between weeks 15 and 20) to check for: